ClinVar Miner

Submissions for variant NM_000448.2(RAG1):c.983G>A (p.Cys328Tyr) (rs121918571)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000820844 SCV000961575 pathogenic Combined cellular and humoral immune defects with granulomas; Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive 2019-12-18 criteria provided, single submitter clinical testing This sequence change replaces cysteine with tyrosine at codon 328 of the RAG1 protein (p.Cys328Tyr). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tyrosine. This variant is present in population databases (rs121918571, ExAC 0.01%). This variant has been observed in individuals affected with Omenn syndrome and with clinical features of severe combined immunodeficiency (PMID: 11133745, 17572155, Invitae). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 13160). This variant has been reported to affect RAG1 protein function (PMID: 18056378, 24290284). For these reasons, this variant has been classified as Pathogenic.
OMIM RCV000014046 SCV000034293 pathogenic Histiocytic medullary reticulosis 2007-12-15 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.